RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,506.70
128.6 (5.41%)
BSENSE

May 07

BSE+NSE Vol: 43.76 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
707.52
653.43
Other Operating Income
0.00
0.00
Total Operating income
707.52
653.43
Raw Material Cost
135.98
110.26
Purchase of Finished goods
138.10
95.14
(Increase) / Decrease In Stocks
-21.99
8.61
Employee Cost
141.48
126.14
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
166.86
153.63
Total Expenditure (Excl Depreciation)
560.43
493.78
Operating Profit (PBDIT) excl Other Income
147.09
159.65
Other Income
25.58
12.68
Operating Profit (PBDIT)
172.67
172.33
Interest
0.89
0.62
Exceptional Items
3.90
82.60
Gross Profit (PBDT)
175.68
254.31
Depreciation
21.48
21.43
Profit Before Tax
154.20
232.88
Tax
39.03
49.64
Provisions and contingencies
0.00
0.00
Profit After Tax
115.17
183.24
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
115.17
183.24
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
115.17
183.24
Equity Capital
13.23
13.23
Face Value
8.0
8.0
Reserves
592.12
517.30
Earnings per share (EPS)
69.64
110.8
Diluted Earnings per share
69.64
110.8
Operating Profit Margin (Excl OI)
20.79%
24.43%
Gross Profit Margin
24.83%
38.92%
PAT Margin
16.28%
28.04%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 8.28% vs 12.26% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -37.15% vs 109.03% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -7.84% vs 24.58% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 43.55% vs 37.78% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of RPG LifeScience. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
707.52
0
707.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
707.52
0
707.52
Raw Material Cost
135.98
0
135.98
Purchase of Finished goods
138.10
0
138.10
(Increase) / Decrease In Stocks
-21.99
0
-21.99
Employee Cost
141.48
0
141.48
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
166.86
0.00
166.86
Total Expenditure (Excl Depreciation)
560.43
0
560.43
Operating Profit (PBDIT) excl Other Income
147.09
0.00
147.09
Other Income
25.58
0
25.58
Operating Profit (PBDIT)
172.67
0
172.67
Interest
0.89
0
0.89
Exceptional Items
3.90
0
3.90
Gross Profit (PBDT)
175.68
0
175.68
Depreciation
21.48
0
21.48
Profit Before Tax
154.20
0
154.20
Tax
39.03
0
39.03
Provisions and contingencies
0.00
0
0.00
Profit After Tax
115.17
0
115.17
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
115.17
0
115.17
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
115.17
0
115.17
Equity Capital
13.23
0
13.23
Face Value
8.00
0
0.00
Reserves
592.12
0
592.12
Earnings per share (EPS)
69.64
0
69.64
Diluted Earnings per share
69.64
0
69.64
Operating Profit Margin (Excl OI)
20.79%
0%
0.00
20.79%
Gross Profit Margin
24.83%
0%
0.00
24.83%
PAT Margin
16.28%
0%
0.00
16.28%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 707.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.28% vs 12.26% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 115.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -37.15% vs 109.03% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 147.13 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.84% vs 24.58% in Mar 2025

Annual - Interest
Interest 0.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.55% vs 37.78% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.80%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025